Literature DB >> 30794430

M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt.

Lan-Xue Zhao1, Yan-Hui Ge1, Jia-Bing Li1, Cai-Hong Xiong1, Ping-Yee Law2, Jian-Rong Xu1, Yu Qiu1, Hong-Zhuan Chen3.   

Abstract

M1 muscarinic acetylcholine receptors are highly expressed in key areas that control cognition, such as the cortex and hippocampus, representing one potential therapeutic target for cognitive dysfunctions of Alzheimer's disease and schizophrenia. We have reported that M1 receptors facilitate cognition by promoting membrane insertion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor AMPA receptor subunit 1 (GluA1) through phosphorylation at Ser845. However, the signaling pathway is still unclear. Here we showed that adenylyl cyclase inhibitor 2',5'-dideoxyadenosine and PKA inhibitor KT5720 inhibited enhancement of phosphorylation of Ser845 and membrane insertion of GluA1 induced by M1 receptor activation. Furthermore, PI3K inhibitor LY294002 and protein kinase B (Akt) inhibitor IV blocked the effects of M1 receptors as well. Remarkably, the increase of the activity of PI3K-Akt signaling induced by M1 receptor activation could be abolished by cAMP-PKA inhibitors. Moreover, inhibiting the mammalian target of rapamycin (mTOR) complex 1, an important downstream effector of PI3K-Akt, by short-term application of rapamycin attenuated the effects of M1 receptors on GluA1. Furthermore, such effect was unrelated to possible protein synthesis promoted by mTOR. Taken together, these data demonstrate that M1 receptor activation induces membrane insertion of GluA1 via a signaling linking cAMP-PKA and PI3K-Akt-mTOR pathways but is irrelevant to protein synthesis.-Zhao, L.-X., Ge, Y.-H., Li, J.-B., Xiong, C.-H., Law, P.-Y., Xu, J.-R., Qiu, Y., Chen, H.-Z. M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt.

Entities:  

Keywords:  GluA1 Ser845; GluA1 trafficking; mTOR; signal transduction

Year:  2019        PMID: 30794430     DOI: 10.1096/fj.201802351R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

1.  PKC and Ras are Involved in M1 Muscarinic Receptor-Mediated Modulation of AMPA Receptor GluA1 Subunit.

Authors:  Mu-Wen Chen; Han Zhu; Cai-Hong Xiong; Jia-Bing Li; Lan-Xue Zhao; Hong-Zhuan Chen; Yu Qiu
Journal:  Cell Mol Neurobiol       Date:  2019-11-13       Impact factor: 5.046

2.  Genomic signatures of artificial selection in the Pacific oyster, Crassostrea gigas.

Authors:  Boyang Hu; Yuan Tian; Qi Li; Shikai Liu
Journal:  Evol Appl       Date:  2021-09-02       Impact factor: 4.929

3.  AMPA Receptor Expression Requirement During Long-Term Memory Retrieval and Its Association with mTORC1 Signaling.

Authors:  Magdalena Pereyra; Ana Belén de Landeta; Juliana Fátima Dalto; Cynthia Katche; Jorge H Medina
Journal:  Mol Neurobiol       Date:  2020-11-26       Impact factor: 5.590

4.  Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy.

Authors:  Luca Gozzelino; Gaga Kochlamazashvili; Sara Baldassari; Albert Ian Mackintosh; Laura Licchetta; Emanuela Iovino; Yu Chi Liu; Caitlin A Bennett; Mark F Bennett; John A Damiano; Gábor Zsurka; Caterina Marconi; Tania Giangregorio; Pamela Magini; Marijn Kuijpers; Tanja Maritzen; Giuseppe Danilo Norata; Stéphanie Baulac; Laura Canafoglia; Marco Seri; Paolo Tinuper; Ingrid E Scheffer; Melanie Bahlo; Samuel F Berkovic; Michael S Hildebrand; Wolfram S Kunz; Lucio Giordano; Francesca Bisulli; Miriam Martini; Volker Haucke; Emilio Hirsch; Tommaso Pippucci
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

Review 5.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.